<DOC>
	<DOCNO>NCT00513786</DOCNO>
	<brief_summary>Purpose study determine effectiveness drug combination carboplatin , paclitaxel , bevacizumab ( Avastin ) patient advanced stage endometrial carcinoma .</brief_summary>
	<brief_title>Evaluation Carboplatin/Paclitaxel/Bevacizumab Treatment Advanced Stage Endometrial Carcinoma</brief_title>
	<detailed_description>The purpose study test effectiveness , safety , tolerability drug combination carboplatin , paclitaxel , bevacizumab ( Avastin ) patient advanced stage endometrial carcinoma . This phase II , open label , single center study . Patients receive carboplatin , paclitaxel , bevacizumab outpatient center intravenous administration . The primary objective study progression free survival 24 month initiation treatment determine toxicity profile drug combination . The secondary objective estimate overall survival tumor response group patient .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Advanced Stage Endometrial Cancer ( Stage 3 4 ) Any Histology include clear cell , serous papillary carcinoma surgery must hysterectomy bilateral salpingooophorectomy chemotherapy initiate 12 week surgery sign inform consent Adequate Endorgan function GOG ( Gynecologic Oncology Group ) Performance Status 0,1,2 Patients must 18 year old Patients may receive radiation treatment endometrial cancer . Patients may measurable nonmeasurable disease . Patient concomitant malignancy nonmelanoma skin cancer Patients prior malignancy disease free 5 year . Patients serious uncontrolled infection , angina serious peripheral neuropathy . Patients whose circumstance permit study completion adequate follow Patients receive prior cytotoxic chemotherapy treatment endometrial cancer include chemotherapy use radiation sensitization .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Endometrial Cancer</keyword>
	<keyword>Advanced Stage Endometrial Cancer</keyword>
	<keyword>Stage 3 4 endometrial cancer</keyword>
	<keyword>Cancer treatment</keyword>
	<keyword>gyn cancer</keyword>
</DOC>